Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01274390
Other study ID # Pro00021198
Secondary ID R01HL101382
Status Completed
Phase N/A
First received January 9, 2011
Last updated February 1, 2017
Start date January 2011
Est. completion date January 2014

Study information

Verified date July 2014
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is an ancillary (add-on) study to the clinical trial entitled Red Cell Storage Duration Study (RECESS), which has clinicaltrials.gov identifier NCT00991341. The RECESS study randomizes cardiac surgery patients to receive either red blood cell units stored for no more than 10 days, or red blood cell units stored for at least 21 days, if they need any red blood cell transfusions during their hospital stay for the surgery.

This ancillary study is entitled Impact of Blood Storage Duration on Physiologic Measures: RECESS Ancillary Physiologic Study (RECAP). The hypothesis of the RECAP study is that there will be differences between the two randomized treatment groups in how much the following measurements change, from shortly before a red blood cell transfusion to shortly after a red blood cell transfusion, and from before surgery to 24 hours after surgery:

- Oxygen saturation in the hand

- Oxygen saturation in the brain

- Blood flow in the small blood vessels under the tongue.

The RECAP study will also investigate whether changes in the measurements listed above are associated with clinical outcomes, including

- The Multi-Organ Dysfunction Score

- Death from any cause

- Major cardiac events

- Major pulmonary events


Recruitment information / eligibility

Status Completed
Enrollment 390
Est. completion date January 2014
Est. primary completion date January 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Eligible and randomized in the RECESS study (NCT00991341)

- At least 18 years old

- Willing to comply with protocol and provide written informed consent for both RECESS and RECAP

- Scheduled to undergo coronary artery bypass (CABG), valve, or combined CABG plus valve surgery

Exclusion Criteria:

- Prior randomization into the RECESS or RECAP studies

- Undergoing off-pump cardiac surgery

- Undergoing a significant concomitant surgical procedure

- Known sickle cell disease

- Participation in a clinical trial (except observational studies or RECESS) within the previous 30 days

- Received any investigational product within prior 30 days

- Not able to be randomized in RECESS

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Brigham and Womens Hospital Boston Massachusetts
United States Massachusetts General Hospital Boston Massachusetts
United States Duke University Medical Center Durham North Carolina
United States University of Minnesota Minneapolis Minnesota

Sponsors (2)

Lead Sponsor Collaborator
Duke University National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Stowell CP, Whitman G, Granger S, Gomez H, Assmann SF, Massey MJ, Shapiro NI, Steiner ME, Bennett-Guerrero E. The impact of red blood cell storage duration on tissue oxygenation in cardiac surgery. J Thorac Cardiovasc Surg. 2016 Nov 19. pii: S0022-5223(16 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in thenar oxygenation saturation From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Secondary Change in downslope of thenar oxygen saturation From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Secondary Change in upslope of thenar oxygen saturation From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Secondary Change in cerebral oxygenation From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Secondary Change in microvascular mean flow index From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Secondary Change in percent perfused vessels From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Secondary Change in capillary density index From a measurement taken within 2 hours prior to the index transfusion, to a measurement taken within 2 hours following the index transfusion.
Secondary Change in thenar oxygen saturation From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Secondary Change in downslope of thenar oxygen saturation From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Secondary Change in upslope of thenar oxygen saturation From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Secondary Change in cerebral oxygenation From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Secondary Change in microvascular mean flow index From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Secondary Change in percent perfused vessels From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Secondary Change in capillary density index From a measurement taken within 6 hours prior to surgery, to a measurement taken 20-28 hours after surgery
Secondary Change in multi-organ dysfunction score From pre-surgery baseline to post-operative Day 7, hospital discharge, or death, whichever occurs first
Secondary All-cause mortality Through post-operative Day 28
Secondary Composite of major cardiac events Through post-operative Day 7, hospital discharge, or death, whichever occurs first
Secondary Composite of major pulmonary events Through post-operative Day 7, hospital discharge, or death, whichever occurs first
See also
  Status Clinical Trial Phase
Recruiting NCT05054179 - Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain Phase 2/Phase 3
Completed NCT04051021 - Non-Pharmacological Interventions on Patient Experience and Healthcare Utilization in Adult Cardiac Surgery Patients N/A
Recruiting NCT04604886 - The Consistency of Cardiac Output Measured by Pulmonary Artery Catheter and LiDCO in Cardiac Surgical Patients N/A
Recruiting NCT04075981 - Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) Phase 3
Completed NCT04062396 - Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction N/A
Recruiting NCT04709705 - DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS) Phase 2/Phase 3
Not yet recruiting NCT05563662 - SURgical Registry of ENDocarditis EuRope
Withdrawn NCT03289104 - Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX N/A
Completed NCT04199039 - Effects of Endotracheal Tube Fixation Methods on Hemodynamic Parameters During Endotracheal Suction N/A
Completed NCT03563196 - Diagnosis Of Pulmonary Complications After Cardiac Surgery In Children
Completed NCT02964026 - Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients N/A
Completed NCT02471001 - The Levels of Anaesthetics in Heart Muscle During Heart Surgery N/A
Completed NCT02325726 - RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery. N/A
Completed NCT01246947 - Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation N/A
Completed NCT01151254 - Comparison of Propofol Based Versus Volatile Based Anesthesia and Postoperative Sedation N/A
Completed NCT00996099 - Continuous Glucose Monitoring Combined With Computer Algorithm for Intensive Insulin Therapy in Cardiosurgical Patients N/A
Completed NCT00821262 - Sevoflurane in Cardiac Surgery Phase 4
Completed NCT00617955 - Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates N/A
Completed NCT00337805 - Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery Phase 2/Phase 3
Completed NCT00336466 - The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS) Phase 2